ORIC Pharmaceuticals Inc Sustainability Reports
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to overcome drug resistance in cancer. The company's pipeline includes small molecule inhibitors targeting various mechanisms that allow tumors to evade current cancer treatments.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 54930033FJRNEYBW0L25
FIGI: BBG00BL5SMR2
1 reports from 2022 to 2022
